Professor David Webb
Christison Chair of Therapeutics and Clinical Pharmacology, University of Edinburgh; WCP2023 President
Country: United Kingdom
Specialty/Research area: Cardiovascular/Clinical Pharmacology
Online profile: https://orcid.org/0000-0003-0755-1756
David is Christison Professor of Therapeutics & Clinical Pharmacology at the University of Edinburgh, a Fellow of the Royal Society of Edinburgh and Academy of Medical Sciences (AMS), and Honorary Fellow of BPS and Faculty of Pharmaceutical Medicine. Through a Wellcome Trust Cardiovascular Award, he created the University/BHF Centre for Cardiovascular Science, and contributed to establishing the Queen’s Medical Research Institute, where he is a Principle Investigator and heads the Hypertension/Renal Section. He leads Edinburgh’s ESH-accredited Hypertension Excellence Centre, and his research focuses on understanding arterial structure and function and improving management of hypertension and renal disease, with translational work on inhibitors of ACE, ET-1, PDE5 and renin. He has received the SKB Silver and Lilly Gold Medals from BPS for research in and contributions to clinical pharmacology respectively. He has an h-Index >100.
David is Executive Member of IUPHAR and its Clinical Division, Deputy Chair of MHRA (the UK’s medicines regulator), and chairs NIBSC’s Scientific Advisory Committee and BPS/Medical Schools Council Prescribing Safety Assessment (PSA) Executive. He is Past-President of BPS, and of the Scottish Society of Physicians, and Honorary President of EACPT (Edinburgh 2009). He has previously chaired the Scottish Medicines Consortium (Scotland’s equivalent of NICE).
David was appointed Commander of the Order of the British Empire (CBE) in the 2020 Queen’s Birthday Honours List.